For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ...

Phase III Vivacity-MG3 trial shows that nipocalimab, an investigational FcRn blocker, significantly the improves symptoms of generalized myasthenia gravis with a manageable safety profile.

KFDA approves Argenxs Vibgart for severe myasthenia gravis treatment KFDA greenlights innovative therapy for muscle weakness ...

A breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied ...

Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.

Apr. 3, 2024 — A routine blood test that measures a patient's inflammation levels could improve the early diagnosis and management of a wide range of debilitating autoimmune diseases.

Korea shifts life science research to data-driven technology for 2025 Koreas Ministry of Science focuses on nurturing ...

Jan. 20, 2025 — Researchers have profiled the molecular structure and features of a key part of the deadly Nipah virus. Experiments in cells showe how changes in the viral polymerase -- a ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms—including reduced physical exercise capacity and reduced cognitive test performances—for a year or more ...

University of Iowa, The Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, USA Objective: The objective of the Predict-HD study is to use genetic, neurobiological and refined clinical ...

Diseases spread through saliva include mononucleosis, strep throat, rotavirus, and even tooth decay. Many diseases can be spread through saliva alone, including viral and bacterial infections. Our ...